News Snapshot:
China is on course to produce its own version of the revolutionary new vaccines that use genetic technology to stimulate the immune system by the end of the year, according to a senior industry figure. The two available mRNA vaccines – produced by Moderna and Pfizer-BioNTech – have a higher efficacy rate than those produced using other forms of technology. “We fully expect that there is a high possibility that a domestic mRNA vaccine will hit the market by this year,” said Feng Duojia, president of the China Association of Vaccines. “We increasingly feel that we must master the core...
